XNK receives certificate of GMP compliance of a manufacturer from the Medical Products Agency

XNK Therapeutics today announced that it has received a GMP manufacturing license and a certificate of GMP compliance from the Swedish Medical Products Agency, which means that the company can produce at scale for its planned clinical studies.

“We are very happy to receive this license. It is an important milestone for XNK, and we are now well positioned for significant value creation with three to four potential phase I/II readouts in our pipeline over the coming three years. The in-house GMP facility provides us with valuable capacity, flexibility and control over our clinical manufacturing which brings competitive advantages going forward. In addition, the close collaboration and proximity between manufacturing and research & innovation ensures efficient process development and organizational learning,” said Johan Liwing, CEO, XNK Therapeutics.

The building phase of the company’s new GMP clean room facility was completed in September 2022. The GMP facility comprises approximately 350 square meters and is located at XNK in the Novum Research Park, co-located with the Karolinska Institutet and the Karolinska University Hospital in Huddinge, Sweden.

“I am proud of the team which has worked hard over the past 18 months to build and validate our new GMP facility and a regulatory compliant Pharmaceutical Quality System. This will enable us of aseptic production of ATMPs for future clinical trials. This is an important step in the company’s ambitious growth plan to enable further larger clinical trials with our natural killer cell-based therapies,” said Linda Brink, Head of QA at XNK Therapeutics.

Life Science Fair Flemingsberg – With a Spotlight on MedTech

In February, over 250 engaged participants, leading voices from the ecosystem, and outstanding exhibitors gathered at Novum Research Park for a full day with a focus on MedTech. The result? A day filled with knowledge, ideas, and new connections where the importance of MedTech for healthcare, competitiveness, and society was at the center – and where Flemingsberg showed itself at its best as a meeting place for Life Science.

Flemingsberg is Growing – A Sustainable and Attractive Neighbourhood in the Making

Flemingsberg is currently undergoing a phase of rapid development, where new rental housing and apartments are helping to strengthen the area’s attractiveness as a residential, education and research hub in southern Greater Stockholm. The expansion of housing is an important part of the long-term development of Campus Flemingsberg and the surrounding area.

From Education to Societal Strength: Police Education and the Fight Against Organized Crime

At a time marked by growing insecurity and increasingly complex crime, the need for long-term solutions is becoming more urgent. As the police training programme at Södertörn University in Flemingsberg celebrates its tenth anniversary, attention is turning to the future. Together with SMOB, the university works with education, research and collaboration to prevent crime and build a safer society.